SecBot SecBot
6-K ·Filed Apr 16, 2026

RDY

DR REDDYS LABORATORIES LTD
NEUTRAL
Impact 2/10
Horizondays Processed7mo ago SEC0001575872-26-000249
Notable filing: 6-K
Actionable Insight • Neutral

No immediate trading implications. Investors should await the actual dividend announcement and financial results, typically released after the board meeting.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60
Entry
$13.06
T+0 close · Apr 16, 2026 · via day close
Latest settled
−1.07%
T+60 · $12.92
Vs SPY
−8.12%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Apr 16 $13.06entry
  2. T+1 · 7mo ago +1.84%α +0.62% · $13.30
  3. T+5 · 7mo ago +3.98%α +3.00% · $13.58
  4. T+20 · 6mo ago −0.54%α −6.35% · $12.99
  5. T+60 · 4mo ago −1.07%α −8.12% · $12.92
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Dr. Reddy's Laboratories announced that its Board of Directors will consider recommending a final dividend for the fiscal year 2025-26. This is a routine disclosure ahead of an upcoming board meeting and contains no financial results or material changes to operations.

Key Facts

  • Company: Dr. Reddy's Laboratories Ltd. (RDY)
  • Filing Type: Form 6-K (foreign private issuer report)
  • Event: Board meeting to consider final dividend for FY 2025-26
  • Date of Filing: April 16, 2026
  • No financial results, guidance, or material operational updates disclosed

Financial Impact

undisclosed amount

dividend

Risk Factors

  • Dividend may be lower than expected or omitted
  • No assurance that dividend will be approved

Market Snapshot

Exchange
NYSE
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001575872-26-000249
Document: 0001575872-26-000249-index.html0001575872-26-000249
Document: 0001575872-26-000249.txt0001575872-26-000249

Track record

73 reports on RDY

Performance horizon

7 of 12 bullish or bearish reports moved the stock their way by T+5. Best: +23.28% at T+20 after the Jun 26, 2026 report. 7 of 12 went positive at some point.

Filters
  1. Nov 16, 2026today 6-K Bullish 4/10 Entry $14.85 Now $14.70 −1.01% settles Nov 23
  2. Nov 10, 20266d ago 6-K Neutral 2/10 Entry $14.86 Now $14.70 −1.08% settles Nov 17
  3. Nov 9, 20267d ago Institutional Cluster Neutral 3/10 Entry $15.05 to $14.70 Now $14.70 −2.33% ▼ −2.33% −0.63% vs SPY
  4. Nov 5, 202611d ago 6-K Neutral 4/10 Entry $14.53 to $14.73 Now $14.70 +1.17% ▲ +1.38% −1.91% vs SPY
  5. Nov 4, 202612d ago 6-K Neutral 2/10 Entry $14.77 to $14.84 Now $14.70 −0.47% ▲ +0.47% +1.39% vs SPY
  6. Nov 2, 202614d ago 144 Bearish 5/10 Entry $14.13 to $15.05 Now $14.70 −4.03% ▼ −6.51% −6.43% vs SPY
  7. Oct 29, 202618d ago 6-K Neutral 2/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  8. Oct 28, 202619d ago 6-K Neutral 3/10 Entry $14.11 to $14.53 Now $14.70 +4.18% ▲ +2.98% +7.70% vs SPY
  9. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
  10. Oct 26, 202621d ago 6-K Neutral 2/10 Entry $13.75 to $14.17 Now $14.70 +6.91% ▲ +3.05% +4.32% vs SPY
Showing 10 of 73

US Market Status

Market Closed · Opens in 5h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 16, 2026